Steven O'Day
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Steven O’Day
Jul 19, 2024, 02:00 |
Blog
I ask Agenus to consider Armenia as the first country to register the BOT/BAL combination: Gevorg Tamamyan
"~20% ORR and 90% alive at 6 months in comparison to ZERO! How many patients…
Jul 18, 2024, 15:20 |
Drugs
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Agenus shared on LinkedIn: "Today, we announced the outcomes of our End-of-Phase 2 meeting and…
Jul 11, 2024, 13:16 |
Blog
Steven O'Day about how immunotherapy stands apart from traditional chemotherapy - Agenus
Agenus shared a post on LinkedIn: . "Did you know immunotherapy activates the body’s own…
Jun 28, 2024, 15:58 |
Insight
Updates on BOT/BAL from ESMOGI24
ESMO GI 2024 is held in Munich, Germany, and online from June 26-29. Organized by…
Jun 28, 2024, 13:48 |
Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 |
Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:15 |
Insight
The clinical utility of liquid biopsies detecting ctDNA in guiding treatment for patients with mCRC - ESMO
ESMO (European Society for Medical Oncology) shared on LinkedIn: "Data from two presentations at ESMOGI24…
Jun 28, 2024, 13:09 |
Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 28, 2024, 13:00 |
Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 18, 2024, 23:25 |
Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 13, 2024, 23:58 |
Insight
Steven O'Day shared the latest data and insights from our botensilimab programs - Agenus
Agenus shared on LinkedIn: "Yesterday, our Chief Medical Officer, Dr. Steven O'Day, joined clinical experts…
Jun 10, 2024, 16:17 |
Blog
Steven O’Day will be presenting an update on botensilimab programs at Nature Conferences’s event - Agenus
Quoting Agenus on X: "Tomorrow, Dr. Steven O’Day will be speaking at Nature Conferences’ Cancer Immunotherapy…
Mar 31, 2024, 23:33 |
Blog
Steven O'Day: Please take one lesson with you as Colorectal Cancer Awareness Month nears it ends - get screened!
Steven O'Day shared a post on LinkedIn: "Please take one lesson with you as Colorectal Cancer…
Mar 18, 2024, 15:36 |
Blog
Steven O’Day: Don’t let Colorectal Cancer Awareness Month pass this year without engaging
Steven O’Day shared on LinkedIn: “Don’t let Colorectal Cancer Awareness Month pass this year without…
Mar 10, 2024, 16:44 |
Blog
Steven O’Day: March is Colorectal Cancer Awareness Month—a time where I am reminded of the resilience and courage of those affected by this disease
Steven O’Day shared on LinkedIn: "March is Colorectal Cancer Awareness Month—a time where I am…
Mar 3, 2024, 05:48 |
Blog
Check out the latest 'Ask the Expert' webinar hosted by Melanoma Research Foundation - Agenus
Agenus shared a post on LinkedIn: ''In case you missed it, check out the latest…
Feb 22, 2024, 17:59 |
Blog
“The Immuno-Oncology Curve” with Dr. Steven O'Day – Guests are Dr. Joseph Grossman and Dr. Benny Johnson
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "In the latest episode…
Jan 9, 2024, 09:37 |
Blog
“The Immuno-Oncology Curve” with Dr. Steven O’Day – Guests are Alexa Morell, Marianne Pearson and Andrew Wortmann
Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "Happy New Year! I’m…
Nov 28, 2023, 16:14 |
Blog
“The Immuno-Oncology Curve" with Dr. Steven O'Day - Guest is Alexander (Lex) Eggermont
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I’m excited to announce…
Nov 20, 2023, 10:30 |
Insight
Steven O'Day: I am thrilled to announce the upcoming launch of “The Immuno-Oncology Curve”
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I am thrilled to…
Nov 19, 2023, 00:23 |
Blog
Steven O'Day: We are looking for an experienced pharma medical director (MD) with experience in oncology and immunotherapy and BLA submissions to join our passionate team and exciting pipeline
Nov 3, 2023, 12:10 |
Drugs
Steven O'Day shared their recent webinar presented by Endpoints News on “The Next I-O Revolution”
Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn: ''Did you catch our…
Nov 1, 2023, 18:54 |
Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 30, 2023, 19:47 |
Opinion
Jeniece Waite: Agenus is hiring clinical scientists
Jeniece Waite, Senior Recruiting Manager at Agenus, shared a post on LinkedIn: "As a Clinical…
Oct 29, 2023, 03:34 |
Drugs
Steven O'Day: The research we shared underscores BOT’s broad potential utility across multiple advanced solid tumors
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "It was an exciting…
Oct 15, 2023, 19:05 |
Blog
Steven O'Day: I am thrilled to be joining Dr. Benjamin Schlechter, Dr. Pashtoon Kasi, and Phuong Ly-Gallagher for an engaging discussion on “The Next I-O Revolution”.
Sep 25, 2023, 16:07 |
Insight
Steven O'Day: Today is World Cancer Research Day, which is a good day for me to share three things.
Quoting Steven O'Day, the Chief Medical Officer at Agenus, on LinkedIn: "Today is World Cancer…
All:
27
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube